AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Takeda’s diabetes drug fasiglifam, TAK 875, shines in Phase III

 Phase 3 drug  Comments Off on Takeda’s diabetes drug fasiglifam, TAK 875, shines in Phase III
May 212013
 

Takeda's diabetes drug fasiglifam shines in Phase III

TAK 875

http://www.ama-assn.org/resources/doc/usan/fasiglifam.pdf GET CAS NO STR MW, ETC HERE

Takeda Pharmaceutical Co has presented positive late-stage data on a new diabetes compound called fasiglifam.

The company announced results of a Phase III trial at the Japan Diabetes Society meeting in Kumamoto,

read all at

http://www.pharmatimes.com/Article/13-05-20/Takeda_s_diabetes_drug_fasiglifam_shines_in_Phase_III.aspx

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: